Presscuff

Presscuff™

The 1st Pressurized Endotracheal Tube

A VUB/UZ Brussels spin-off

"This is genius and so simple"

– An (unrelated) anesthesiologist

Our mission

To reduce VAP in hospital patients and assist ICU's in saving lives

Due to its high rate of mortality, ventilator-associated pneumonia (VAP) is one of the most dreaded infections that can strike a hospital patient. It afflicts a considerable percentage of those in intensive care units (ICUs) so weakened by illness or trauma that they need mechanical help to breathe.

Our mission is to help prevent VAP and save lives while doing so.

Recurso 21

Our story

How Presscuff came to be

bateria

The problem - Ventilator Associated Pneumonia

In Intensive Care units in hospitals all around the world, patients using breathing aids are intubated. On the inside of those tubes, oxygen flows towards the lungs. But on the outside, saliva/secretions drip down towards the lungs as well. As those contain bacteria, this often leads to severe pneumonia, or VAP (Ventilator Associated Pneunomia).

The idea - While others try to fight and close the gap...

Most endotracheal tube producers have tried close the gap and reduce the leakage of those secretions by adding cuffs (a sort of balloons) on the outside of the tube. As this did not stop the leakage, they have tried everything from multiple cuffs, different forms & material…but it seems impossible to close the gap fully as little folds/channels always remain.

lungs-with-bacteria
air-flow

The solution - Presscuff uses it to its advantage

The Presscuff however, does exactly the opposite and uses that gap to its
advantage: it adds pressure in between two cuffs. As the air pressure tries to
escape through the little channels of the upper cuffs, it blocks the saliva from
trickling down (towards the lungs).

The product - The first pressurized endotracheal tube

The Presscuff is the first pressurized endotracheal tube, unique in its kind. It is
developed by the UZ Brussels and VUB, patented and has been successfully tested on 12 Intensive Care patients.

endotracheal-tube

The problem

In Intensive Care units in hospitals all around the world, patients using breathing aids are intubated. On the inside of those tubes, oxygen flows towards the lungs. But on the outside, saliva/secretions drip down towards the lungs as well. As those contain bacteria, this often leads to severe pneumonia, or VAP (Ventilator Associated Pneunomia).
lungs-with-bacteria

The idea

Most endotracheal tube producers have tried close the gap and reduce the leakage of those secretions by adding cuffs (a sort of balloons) on the outside of the tube. As this did not stop the leakage, they have tried everything from multiple cuffs, different forms & material…but it seems impossible to close the gap fully as little folds/channels always remain.

endotracheal-tube

The solution

In Intensive Care units in hospitals all around the world, patients using breathing aids are intubated. On the inside of those tubes, oxygen flows towards the lungs. But on the outside, saliva/secretions drip down towards the lungs as well. As those contain bacteria, this often leads to severe pneumonia, or VAP (Ventilator Associated Pneunomia).
air-flow

The product

The PressCuff is the first pressurized endotracheal tube, unique in its kind. It is developed by the UZ Brussels and VUB, patented and tested on Intensive Care patients.
logo-main-3

Presscuff in action

Play Video

The Presscuff team

Founders

Emiel Suijs

Co-founder of Presscuff. Before that, Miel was the chief nurse at the intensive care unit of UZ Brussels, where invented the Presscuff. Since then, he has been working rentlessly to improve and promote this product.

Evert van Meeuwen

Co-founder of Presscuff, with experience in financial markets and start-ups. Since 2018, Evert, together with Emiel, has been the driving force behind Presscuff.

Benjamin De Vlam

Co-founder of Presscuff. As a Doctor of Medicine with a passion for entrepreneurship and healthcare, Benjamin is responsible for Operations & contacts with the hospitals.

Advisory Board

Daniel Chapiro

Mechanical Engineer, PHD, Stanford University

Joop Jonckheer

Prof., Dr., and ad interim head of intensive care UZ Brussel

Jan Vanden Abeele

Professor
Health Finance

Stijn Blot

Senior Full Professor
Ghent University

Partners

Institutions and people that help make Presscuff possible

logo
uzb-black
og_image_logo-bioville-horz-cmyk-bl
mdk-marketing-consultancy

Our Mission

To reduce VAP and assist ICU's in saving lives

Due to its high rate of mortality, ventilator-associated pneumonia (VAP) is one of the most dreaded infections that can strike a hospital patient. It afflicts a considerable percentage of those in intensive care units (ICUs) so weakened by illness or trauma that they need mechanical help to breathe.

Our mission is to help prevent VAP and save lives while doing so.

Recurso 47

What others say about Presscuff

mail-doctor
Most anesthesiologists we have spoken with have been enthusiastic about the idea and the prognosis of less VAP cases: “This is genius & so simple” An (unrelated) anesthesiologist when he first heard of Presscuff.

The academic world has also shown interest in Presscuff. 
In one paper, we found the following comment:

“From a clinical point of view, this new tracheal tube is quite interesting, especially for ICU patients with a high risk for pneumonia”

female-doctor

Contact Us

We're open to questions, comments and suggestions related to Presscuff.

Presscuff

The 1st Pressurized Endotracheal Tube

A VUB/UZ Brussels spin-off

"This is genius and so simple"

Our Mission

To reduce VAP in hospital patients and assist ICU's in saving lives

Due to its high rate of mortality, ventilator-associated pneumonia (VAP) is one of the most dreaded infections that can strike a hospital patient. It afflicts a considerable percentage of those in intensive care units (ICUs) so weakened by illness or trauma that they need mechanical help to breathe.

Our mission is to help prevent VAP and save lives while doing so.

Our story

The problem

Ventilator Associated Pneumonia
In Intensive Care units in hospitals all around the world, patients using breathing aids are intubated. On the inside of those tubes, oxygen flows towards the lungs. But on the outside, saliva/secretions drip down towards the lungs as well. As those contain bacteria, this often leads to severe pneumonia, or VAP (Ventilator Associated Pneunomia).
bateria

The idea

While others try to close the gap...
Most endotracheal tube producers have tried close the gap and reduce the leakage of those secretions by adding cuffs (a sort of balloons) on the outside of the tube. As this did not stop the leakage, they have tried everything from multiple cuffs, different forms & material…but it seems impossible to close the gap fully as little folds/channels always remain.
lungs-with-bacteria

The solution

Presscuff uses it to its advantage
The Presscuff however, does exactly the opposite and uses that gap to its advantage: it adds pressure in between two cuffs. As the air pressure tries to escape through the little channels of the upper cuffs, it blocks the saliva from trickling down (towards the lungs).
air-flow

The product

The first pressurized endotracheal tube
The Presscuff is the first pressurized endotracheal tube, unique in its kind. It is developed by the UZ Brussels and VUB, patented and has been successfully tested on 12 Intensive Care patients.
endotracheal-tube

Presscuff in action

Play Video

The Presscuff Team

Founders

Emiel Suijs

Co-founder of Presscuff. Before that, Miel was the chief nurse at the intensive care unit of UZ Brussels, where invented the Presscuff. Since then, he has been working rentlessly to improve and promote this product.

Evert van Meeuwen

Co-founder of Presscuff, with experience in financial markets and start-ups. Since 2018, Evert, together with Emiel, has been the driving force behind Presscuff.

Benjamin De Vlam

Co-founder of Presscuff. As a Doctor of Medicine with a passion for entrepreneurship and healthcare, Benjamin is responsible for Operations & contacts with the hospitals.

Advisory Board

Daniel Chapiro

Mechanical Engineer, PHD, Stanford university

Joop Jonckheer

Prof., Dr. and ad interim head of Intensive care UZ Brussel

Jan Vanden Abeele

Prof. Health Finance

Stijn Blot

Senior Full Professor
Gent University

Partners

Institutions and people that help make Presscuff possible

What others say about Presscuff

mail-doctor

Most anesthesiologists we have spoken with have been enthusiastic about the idea and the prognosis of less VAP cases:

“This is genius & so simple” An (unrelated) anesthesiologist when he first heard of Presscuff.

female-doctor

The academic world has also shown interest in Presscuff. 
In one paper, we found the following comment:

“From a clinical point of view, this new tracheal tube is quite interesting, especially for ICU patients with a high risk for pneumonia”

Contact Us

We're open to questions, comments and suggestions related to Presscuff.
Scroll to Top